JPMorgan Chase & Co. vs AbbVie Inc.
JPMorgan Chase & Co. is worth $947.643B, 2.0× the $464.575B market cap of AbbVie Inc.. Updated daily.
| Metric | AbbVie Inc.ABBV  | |
|---|---|---|
| Market cap | $947.643B | $464.575B |
| Global rank | #1 | #2 |
| Share price | $356.50 | $262.90 |
| Change | -1.53% | +5.12% |
| Revenue | $181.847B | $61.160B |
| Net income | $57.048B | $4.226B |
| Country | United States | United States |
| Sector | Financial Services | Healthcare |
Want a wider comparison? Compare up to five companies.
Related comparisons
Frequently asked questions
- Is JPMorgan Chase & Co. bigger than AbbVie Inc.?
- JPMorgan Chase & Co. has a market cap of $947.643B against $464.575B for AbbVie Inc., making it 2.0 times as valuable.
- Which company earns more, JPM or ABBV?
- JPMorgan Chase & Co. reported net income of $57.048B and AbbVie Inc. reported $4.226B in their most recent annual periods.